DE69321585D1 - PArENTERALE LÖSUNGEN ENTHALTEND 3-DIALKYLAMINOETHOXYBENZOYLBENZOFURANE - Google Patents

PArENTERALE LÖSUNGEN ENTHALTEND 3-DIALKYLAMINOETHOXYBENZOYLBENZOFURANE

Info

Publication number
DE69321585D1
DE69321585D1 DE69321585T DE69321585T DE69321585D1 DE 69321585 D1 DE69321585 D1 DE 69321585D1 DE 69321585 T DE69321585 T DE 69321585T DE 69321585 T DE69321585 T DE 69321585T DE 69321585 D1 DE69321585 D1 DE 69321585D1
Authority
DE
Germany
Prior art keywords
solutions containing
parrteral
dialkylaminoethoxybenzoylbenzofurane
diethylaminoethoxybenzoyl
benzofurans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69321585T
Other languages
English (en)
Other versions
DE69321585T2 (de
Inventor
Seymour Ehrenpreis
John C Somberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academic Pharmaceuticals Inc
Original Assignee
Academic Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academic Pharmaceuticals Inc filed Critical Academic Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69321585D1 publication Critical patent/DE69321585D1/de
Publication of DE69321585T2 publication Critical patent/DE69321585T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
DE69321585T 1992-04-01 1993-03-29 PArENTERALE LÖSUNGEN ENTHALTEND 3-DIALKYLAMINOETHOXYBENZOYLBENZOFURANE Expired - Fee Related DE69321585T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/861,608 US5234949A (en) 1992-04-01 1992-04-01 Parenteral solutions containing amiodarone in acetate buffer solution
PCT/US1993/002919 WO1993019753A1 (en) 1992-04-01 1993-03-29 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans

Publications (2)

Publication Number Publication Date
DE69321585D1 true DE69321585D1 (de) 1998-11-19
DE69321585T2 DE69321585T2 (de) 1999-03-04

Family

ID=25336272

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69321585T Expired - Fee Related DE69321585T2 (de) 1992-04-01 1993-03-29 PArENTERALE LÖSUNGEN ENTHALTEND 3-DIALKYLAMINOETHOXYBENZOYLBENZOFURANE

Country Status (10)

Country Link
US (1) US5234949A (de)
EP (1) EP0633777B1 (de)
JP (1) JP3253302B2 (de)
AT (1) ATE172115T1 (de)
AU (1) AU3969593A (de)
CA (1) CA2133324C (de)
DE (1) DE69321585T2 (de)
IL (1) IL105270A (de)
WO (1) WO1993019753A1 (de)
ZA (1) ZA932304B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735978B1 (fr) * 1995-06-30 1997-09-19 Sanofi Sa Composition pharmaceutique d'amiodarone pour administration parenterale
US6030998A (en) * 1997-06-27 2000-02-29 Academic Pharmaceuticals, Lp Methods for treating arrhythmia using acetate buffer solutions of amiodarone
US5981514A (en) * 1998-02-12 1999-11-09 Somberg; John C. (N-alkyl-N-hydroxymethylamino)alkoxybenzoylbenzofurans and the phosphate esters thereof
US6479541B1 (en) 2000-03-30 2002-11-12 Baxter International Amiodarone-containing parenteral administration
HUP0304086A3 (en) * 2001-03-29 2005-02-28 Baxter Internat Inc Deerfield Premixed amiodarone solution for parenteral use and method for making the same
US20020143051A1 (en) 2001-03-29 2002-10-03 Doty Mark J. Premixed amiodarone parenteral solution and method for making the same
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
US20090270496A1 (en) * 2007-05-03 2009-10-29 Courchesne William E Antifungal compounds
EP2335686A1 (de) 2009-12-21 2011-06-22 LEK Pharmaceuticals d.d. Wässrige intravenöse Nanosuspension mit minimalen Nebenwirkungen
AU2011264919A1 (en) 2010-06-11 2013-01-10 Baxter Healthcare S.A. Formulations including amiodarone and salts thereof and methods of their manufacture and use
US9642828B2 (en) 2014-09-23 2017-05-09 Sun Pharmaceutical Industries Limited Parenteral dosage form of amiodarone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) * 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
FR2550091B1 (fr) * 1983-08-02 1986-05-23 Sanofi Sa Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne
US4831054A (en) * 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
ATE89164T1 (de) * 1989-02-20 1993-05-15 Soorianarain Baligadoo Pharmazeutische herzschuetzende zusammensetzungen enthaltend amiodaron, ein nitroderivat, naemlich isosorbiddinitrat, und gegebenenfalls einen betablocker.

Also Published As

Publication number Publication date
EP0633777B1 (de) 1998-10-14
IL105270A0 (en) 1993-08-18
EP0633777A1 (de) 1995-01-18
ATE172115T1 (de) 1998-10-15
CA2133324A1 (en) 1993-10-14
IL105270A (en) 1999-11-30
CA2133324C (en) 2005-02-01
WO1993019753A1 (en) 1993-10-14
JPH08500330A (ja) 1996-01-16
US5234949A (en) 1993-08-10
DE69321585T2 (de) 1999-03-04
ZA932304B (en) 1994-09-15
JP3253302B2 (ja) 2002-02-04
AU3969593A (en) 1993-11-08

Similar Documents

Publication Publication Date Title
FI933656A0 (fi) 2,4-diaminokinazolinderivat, som foerstaerker antitumoeraktivitet
DE58905458D1 (de) Endoskop, insbesondere Arthroskop.
DE68922176D1 (de) Doppelblick-Arthroskop.
ITGE930012A0 (it) Cannula laparoscopica.
DE69204906T2 (de) 2-Hydroxy-2-phenylethylaminderivate als Beta-3-adrenoceptor Agonisten.
DE69203695T2 (de) Sauerstoff aufnehmende Zusammensetzung.
DE69013896T2 (de) Wasserstoffperoxidlösungen.
FI912348A (fi) Stabiliserad fgf sammansaettning.
ATE172115T1 (de) Parenterale lösungen enthaltend 3- dialkylaminoethoxybenzoylbenzofurane
IT1248475B (it) Composti di inclusione di nimesulide con ciclodestrine
DE3785956D1 (de) Adressuebersetzungsschaltung.
FI883855A0 (fi) Foerfarande och koppling foer automatisk, pao en raeknare baserad reglering av frekvensen i en radiotelefon.
DE69227515T2 (de) Schaum stabilisierende agentien und bittermacher aus hopfen
FR2693880B1 (fr) Bijoux transformables.
DE69101652D1 (de) Behandlungsofen.
FI890864A0 (fi) Anvaendning av 1,4-dihydropyridinderivat.
FI911258A (fi) Foer kylmaskin, i synnerhet foer hushaollskylskaop avsedd plaotkondensator.
DE69110999D1 (de) Dynamische Pufferschaltung.
NL190962C (nl) Stelling.
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
IT8920361A0 (it) Procedimento per la conservazione del perborato monoidrato.
NL192568B (nl) Glasrasteel.
ES1021745Y (es) Cuadro vitral autoiluminado.
ES1009168Y (es) Mesa-carro convertible.
ES1024831Y (es) Edredon convertible.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee